Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.30% is 97% below its 5-year average of 11.65%, near the low end of its 5-year range (0.30%–23.33%).
As of the fiscal period ended Tuesday, June 30, 2026. 98.19% below its 12-month average of 16.69%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.30%.
DEBT TO ASSETS RATIO
0.30%
DEBT TO ASSETS RATIO AVG TTM
16.69%
DEBT TO ASSETS RATIO AVG 3Y
14.12%
DEBT TO ASSETS RATIO AVG 5Y
11.65%
DEBT TO ASSETS RATIO AVG 10Y
10.07%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-98.19%
CURRENT VS 3Y AVG
-97.86%
CURRENT VS 5Y AVG
-97.41%
CURRENT VS 10Y AVG
-97.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
+201.74%
vs the sector median at left
Aldeyra The
Market Cap
$57.63M
Debt to Assets Ratio
0.30%
TTM Avg
16.69%
3Y Avg
14.12%
5Y Avg
11.65%
Market Cap
$58.55M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$56.97M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$59.16M
Debt to Assets Ratio
0.74%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$56.52M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aldeyra The (ALDX) | $57.63M | 0.30% | 16.69% | 14.12% | 11.65% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.55M | 0.00% | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.97M | 0.01% | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $59.16M | 0.74% | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $56.52M | 0.00% | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $59.70M | 0.09% | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $55.97M | 0.14% | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $55.06M | 0.84% | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $54.79M | 0.10% | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $54.48M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.3%
Debt/Equity
0.00
Current Ratio
4.91
Interest Coverage
-18.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.30% |
| 2026-03-31 | 23.33% |
| 2025-12-31 | 21.55% |
| 2025-09-30 | 19.98% |
| 2025-06-30 | 18.31% |
| 2025-03-31 | 16.70% |
| 2024-12-31 | 14.63% |
| 2024-09-30 | 13.31% |
| 2024-06-30 | 12.41% |
| 2024-03-31 | 11.08% |
| 2023-12-31 | 10.56% |
| 2023-09-30 | 10.99% |
| 2023-06-30 | 10.38% |
| 2023-03-31 | 9.58% |
| 2022-12-31 | 8.87% |
| 2022-09-30 | 8.40% |
| 2022-06-30 | 7.92% |
| 2022-03-31 | 7.13% |
| 2021-12-31 | 6.80% |
| 2021-09-30 | 6.40% |
| 2021-06-30 | 6.03% |
| 2021-03-31 | 10.46% |
| 2020-12-31 | 18.39% |
| 2020-09-30 | 17.00% |
| 2020-06-30 | 20.84% |
| 2020-03-31 | 23.55% |
| 2019-12-31 | 19.54% |
| 2019-09-30 | 18.94% |
| 2019-06-30 | 0.44% |
| 2019-03-31 | 0.43% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 3.63% |
| 2018-06-30 | 3.11% |
| 2018-03-31 | 3.29% |
| 2017-12-31 | 3.03% |
| 2017-09-30 | 2.71% |
| 2017-06-30 | 5.01% |
| 2017-03-31 | 4.19% |
| 2016-12-31 | 5.23% |
| 2016-09-30 | 4.49% |
| 2016-06-30 | 3.96% |
| 2016-03-31 | 5.53% |
| 2015-12-31 | 4.57% |
| 2015-09-30 | 4.09% |
| 2015-06-30 | 3.75% |
| 2015-03-31 | 7.92% |
| 2014-12-31 | 14.26% |
| 2014-09-30 | 11.99% |
| 2014-06-30 | 10.36% |
| 2014-03-31 | 47.05% |
| 2013-12-31 | 33.99% |
| 2013-09-30 | 12.44% |
| 2012-12-31 | 21.90% |
